New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareHGH Fragment 176-191 vs Nonapeptide-1

HGH Fragment 176-191 vs Nonapeptide-1

Side-by-side comparison of key properties, dosing, and research.

Fat Loss & Metabolic
HGH Fragment 176-191
Skin & Cosmetic
Nonapeptide-1
Summary
HGH Fragment 176-191 (also known as AOD-9604) is a stabilized, modified fragment of the human growth hormone molecule corresponding to amino acids 176–191 with an addition of a tyrosine residue at the N-terminus. It retains HGH's fat-burning properties without the anabolic, diabetogenic, or IGF-1-stimulating effects.
Nonapeptide-1 is a synthetic 9-amino acid peptide that inhibits melanin production by blocking α-MSH (alpha-melanocyte stimulating hormone) receptor binding. Used in cosmetic formulations for skin lightening and evening skin tone, it is particularly effective for UV-induced and hormonal hyperpigmentation.
Half-Life
~30 minutes
Not applicable (topical)
Admin Route
SubQ
Topical
Research
Typical Dose
250–500 mcg
0.05–0.5% concentration in formulation
Frequency
1–3 times daily
Twice daily
Key Benefits
  • Selective fat burning without anabolic side effects
  • Reduces visceral and subcutaneous fat
  • No insulin resistance or blood glucose disruption
  • Does not stimulate IGF-1
  • May support cartilage and bone repair (at higher doses)
  • No effect on growth or organ size
  • Inhibits UV-induced tanning and hyperpigmentation
  • Reduces hormonal melasma
  • Evens skin tone at receptor level
  • Well-tolerated with minimal irritation
  • Complementary to tyrosinase inhibitors for enhanced brightening
  • Reduces post-inflammatory hyperpigmentation
Side Effects
  • Injection site irritation
  • Temporary lethargy
  • Headache (rare)
  • Nausea (rare)
  • Generally very well-tolerated
  • Rare contact sensitivity in susceptible individuals
  • Theoretical risk of excessive depigmentation with prolonged high-concentration use
Stacks With